PCR Corp
Manchester, M13 0AF, United Kingdom
NCT Number: NCT07517900
The objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Manchester, M13 0AF, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Topical skin serum containing Mitopure
Time frame: 2 weeks
Visual evaluation by an expert clinical grader at Baseline and Week 2 for skin condition.
Time frame: 2 weeks
Subjective evaluation of product traits assessed via questionnaire after 2 weeks.
Product traits will be assessed by the subjects with a list of closed questions with the following predefined identical options to tick:
2 = Fully disagree;
1 = Rather disagree;
Looking for future studies?
Notify MeAmazentis SA
Industry
A Clinical Safety in Use Study of 30 Healthy Volunteers to Investigate the Safety of 1 Test Article Following Repeated Applications
Acronym: SIU-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07567430
Eclampsia, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06335199
Brain Diseases, Cardiovascular Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT07504952
Healthy Adult
Loughborough, United Kingdom
View Trial DetailsNCT07515417
Dyssomnias, Health Adult Subjects
Mecca, Saudi Arabia
View Trial Details